MicroRNAs in diabetes: Tiny players in big disease

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 221-232

  Pandey, Amit K ^a   Agarwal, Priyanka ^a   Kaur, Kirandeep ^a   Datta, Malabika ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Diabetes; Diabetic complications; Glucose; Insulin; Lipid; MicroRNA

Indexed keywords

MICRORNA;

DIABETES MELLITUS; DISEASE COURSE; EPIDEMIC; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VALVULAR HEART DISEASE;

EID: 66749146650     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218169     Document Type: Review

References (100)

1. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA: Short RNAs repress translation after initiation in mammalian cells. Mol Cell 2006;21:533-542.
2. Zhang B, Farwell MA: microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008; 12:3-21.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N: Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-114.
4. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I: A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006;126:1203-1217.
5. Hwang HW, Mendell JT: MicroRNAs in cell proliferation cell death and tumorigenesis. Br J Cancer 2006;94:776-780.
6. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261.
7. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007;25:387-392.
8. Gregory RI, Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509-3512.
9. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M: MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-424.
10. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, KotelianskyV, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984.
11. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D: microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci U S A 2008;105:17830-17835.
12. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA: A miRNA signature of prion induced neurodegeneration. PLoS ONE 2008;3e:3652.
13. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De SB: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 2008;105:6415-6420.
14. Ghosh Z, Mallick B, Chakrabarti J: Cellular versus viral microRNAs in hostvirus interaction. Nucleic Acids Res 2009;37:1035-1048.
15. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T: Identification of virus-encoded microRNAs. Science 2004;304:734-736.
16. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T: Identification of microRNAs of the herpesvirus family. Nat Methods 2005;2:269-276.
17. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C: Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007;81:829-834.
18. Tang X, Tang G, Ozcan S: Role of microRNAs in diabetes. Biochim Biophys Acta 2008;1779:697-701.
19. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tusch lT, Rajewsky N, Rorsman P, Stoffel M: A pancreatic isletspecific microRNA regulates insulin secretion. Nature 2004;432:226-230.
20. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R: Alterations in microRNA expression contribute to fatty acidinduced pancreatic beta-cell dysfunction. Diabetes 2008;57:2728-2736.
21. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
22. Gauthier BR, Wollheim CB: MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 2006;12:36-38.
23. Cuellar TL, McManus MT: MicroRNAs and endocrine biology. J Endocrinol 2005;187;327-332.
24. Bravo-Egana V, Rosero S, Molano RD, Pileggi A, Ricordi C, Dominguez-Bendala J, Pastori RL: Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun 2008;366:922-926.
25. Ouaamari AE, Baroukh N, Martens GA, Lebrun P, Pipeleers D, Van OE: miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucoseinduced biological responses in pancreatic beta-cells. Diabetes 2008;57:2708-2717.
26. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T, Takeda A, Tsuchihashi D, Nishizawa A, Ogawa W, Fujimoto Y, Okamura H, Arden KC, Herrera PL, Noda T, Kasuga M: Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet 2006;38:589-593
27. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH: Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007;5:e203.
28. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R: MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006;281:26932-26942.
29. Coppola T, Frantz C, Perret-Menoud V, Gattesco S, Hirling H, Regazzi R: Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol Biol Cell 2002;13:1906-1915.
30. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T: Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 2005;171:99-109.
31. Baroukh N, Ravier MA, Loder MK, Hill EV, BounacerA, ScharfmannR, RutterGA, Van OE: MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic betacell lines. J Biol Chem 2007;282:19575-19588.
32. Tang X, Muniappan L, Tang G, Ozcan S: Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 2009;15:287-293.
33. Vousden KH, Lane DP: p53 in health and disease. Nat Rev Mol Cell Biol 2007;8:275-283.
34. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, MacDougald OA, Cho KR, Fearon ER: p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298-1307.
35. Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ: Protein kinase B/ Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells INS-1. J Biol Chem 2002;277:49676-49684.
36. Kim WH, Lee JW, Gao B, Jung MH: Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 2005;17:1516-1532.
37. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaB-dependent induction of microRNA miR-146 an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006;103:12481-12486.
38. Dunne A, O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003;171:re3.
39. Ortis F, Cardozo AK, Crispim D, Storling J, Mandrup-Poulsen T, Eizirik DL: Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid sustained and nonoscillatory nuclear factor-kappaB activation. Mol Endocrinol 2006;20:1867-1879.
40. Abderrahmani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, Yang J Y, Regazzi R, Widmann C, Waeber G: Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 2007;50:1304-1314.
41. He A, Zhu L, Gupta N, Chang Y, Fang F: Overexpression of micro ribonucleic acid 29 highly up-regulated in diabetic rats leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007;21:2785-2794.
42. Baroni MG, Arca M, Sentinelli F, Buzzetti R, Capici F, Lovari S, Vitale M, Romeo S, Di MU: The G972R variant of the insulin receptor substrate-1 IRS-1 gene body fat distribution and insulin-resistance. Diabetologia 2001;44:367-372.
43. Marini MA, Frontoni S, Mineo D, Bracaglia D, Cardellini M, De NP, Baroni A, D'Alfonso R, Perna M, Lauro D, Federici M, Gambardella S, Lauro R, Sesti G: The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2003;88:3368-3371.
44. Zeng W, Peng J, Wan X, Chen S, Song H: The mutation of insulin receptor substrate-1 gene in Chinese patients with non-insulin-dependent diabetes mellitus. Chin Med J Engl 2000;113:80-83.
45. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R: Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells: J Biol Chem 2007;282:32582-32590.
46. Lewis GF, Carpentier A, Adeli K, Giacca A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-229.
47. Xu P, Vernooy SY, Guo M, Hay BA: The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 2003;13:790-795.
48. Teleman AA, Maitra S, Cohen SM: Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev 2006;20:417-422.
49. Blaumueller CM, Mlodzik M: The Drosophila tumor suppressor expanded regulates growth apoptosis and patterning during development. Mech Dev 2000;92:251-262.
50. Boedigheimer M, Bryant P, Laughon A: Expanded a negative regulator of cell proliferation in Drosophila shows homology to the NF2 tumor suppressor. Mech Dev 1993;44:83-84.
51. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98.
52. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-689.
53. Wilfred BR, Wang WX, Nelson PT: Energizing miRNA research: a review of the role of miRNAs in lipid metabolism with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007;91:209-217.
54. Baskerville S, Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005;11:241-247.
55. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, Dean NM, Freier SM, Bennett CF, Lollo B, Griffey R: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004;279:52361-52365.
56. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z: MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007;282:12363-12367.
57. Miano JM: Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593.
58. Treisman R: The serum response element Trends Biochem. Sci 1992;17:423-426.
59. Johansen FE, Prywes R: Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim Biophys Acta 1995;1242:1-10.
60. Fisher SA, Walsh K, Forehand CJ: Characterization of cardiac gene cis-regulatory elements in the early stages of chicken heart morphogenesis. J Mol Cell Cardiol 1996;28:113-122.
61. + exchanger gene. J Biol Chem 1999;274:12819-12826.
62. Zhang X, Chai J, Azhar G, Sheridan P, Borras AM, Furr MC, Khrapko K, Lawitts J, Misra RP, Wei JY: Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem 2001b;276:40033-40040.
63. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J, Misra RP, Wei JY: Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 2001a;280:H1782-H1792.
64. Nelson TJ, Balza R Jr, Xiao Q, Misra RP: SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 2005;39:479-489.
65. Collins KK, Van Hare GF: Advances in congenital long QT syndrome. Curr Opin Pediatr 2006;18:497-502.
66. Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z: Down-regulation of miR-1/miR-133 contributes to reexpression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 2008;283:20045-20052.
67. Moosmang S, Stieber J, Zong X, Biel M, Hofmann F, Ludwig A: Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur J Biochem 2001;268:1646-1652.
68. Biel M, Schneider A, Wahl C: Cardiac HCN channels: structure function and modulation.Trends Cardiovasc Med 2002;12:206-212.
69. Michels G, Er F, Khan I, Sudkamp M, Herzig S, Hoppe UC: Single-channel properties support a potential contribution of hyperpolarizationactivated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation 2005;111:399-404.
70. Plotnikov AN, Bucchi A, Shlapakova I, Danilo P Jr, Brink PR, Robinson RB, Cohen IS, Rosen MR: HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with If blockade. Heart Rhythm 2008;5:282-288.
71. Stilli D, Sgoifo A, Macchi E, Zaniboni M, De IS, Cerbai E, Mugelli A, Lagrasta C, Olivetti G, Musso E: Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats. Am J Physiol Heart Circ Physiol 2001;280:H142-H150.
72. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, Giunti G, Mugelli A: Characterization of the hyperpolarization-activated current If in ventricular myocytes from human failing heart. Circulation 1997;95:568-571.
73. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ: Hyperpolarizationactivated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998;97:55-65.
74. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C Bai Y, Wang H, Chen G, Wang Z: The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491.
75. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM: Microrna-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2009;36:181-188.
76. Chen HS, Shan YX, Yang TL, Lin HD, Chen JW, Lin SJ, Wang PH: Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 2005;54:175-181.
77. Shan YX, Yang TL, Mestril R, Wang PH: Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 2003;278:45492-45498.
78. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22:736-744
79. Price RG, Hudson BG: 1987 In Renal Basement Membranes in Health and Disease pp 1-439 RG Price and BG Hudson Eds Academic Press Boston.
80. Yin HB, Brown T, Wilkinson JS, Eason RW, Melvin T: Submicron patterning of DNA oligonucleotides on silicon. Nucleic Acids Res 2004;32:e118.
81. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, NatarajanR: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 2007;104:3432-3437.
82. Romberger DJ: Fibronectin. Int J Biochem Cell Biol 1997;29:939-943.
83. Schwarzbauer JE, Sechler JL: Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. Curr Opin Cell Biol 1999;11:622-627.
84. Wang Q, Wang Y, Minto AW, Wang J, Shi Q ,Li X, Quigg RJ: MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008;22:4126-4135.
85. BrownleeM: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
86. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D: Cellular receptors for advanced glycation end products Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521-1528.
87. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N , Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J. Stern D, Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
88. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002;106:2827-2835.
89. Shanmugam N, Reddy MA, Natarajan R: Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b a Ligand of the Receptor for Advanced Glycation End Products. J Biol Chem 2008;283:36221-36233.
90. Kopreski MS, Benko Fa, Gocke DC: Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 2001;945:172-178.
91. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C: Plasma placental RNA allelic ratio permits non invasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-223.
92. Swarup V, Rajeswari RM: Circulating cellfree nucleic acids-a promising noninvasive tool for early detection of several human diseases. FEBS Lett 2007;581:795-799.
93. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
94. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 2008;105:10513-10518.
95. Czech MP: MicroRNAs as therapeutic targets. The New Eng J Med 2006; 354:1194-1195.
96. Uprichard SL, Boyd B, Althage A, Chisari FV: Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci 2005;102:773-778.
97. Xia H, Mao Q, Paulson HL, Davidson BL: siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol 2002;20:1006-1010.
98. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L: A lentivirus-based system to functionally silence genes in primary mammalian cells stem cells and transgenic mice by RNA interference. Nature Genet 2003;33:401-406.
99. Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS: Suppression of mouse rhodopsin expression in vivo by A AV mediated siRNA delivery. Vision Res 2007;47:1202-1208.
100. Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK, Rajeev KG, Nakayama T, Charrise K, Ndungo EM, Zimmermann T, Koteliansky V, Manoharan M, Stoffel M: Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnol 2007;25:1149-1157.